• Je něco špatně v tomto záznamu ?

The C-terminal segment of yeast BMH proteins exhibits different structure compared to other 14-3-3 protein isoforms

D. Veisova, L. Rezabkova, M. Stepanek, P. Novotna, P. Herman, J. Vecer, T. Obsil, V. Obsilova

. 2010 ; 49 (18) : 3853-3861.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025092

Yeast 14-3-3 protein isoforms BMH1 and BMH2 possess a distinctly variant C-terminal tail which differentiates them from the isoforms of higher eukaryotes. Their C-termini are longer and contain a polyglutamine stretch of unknown function. It is now well established that the C-terminal segment of 14-3-3 proteins plays an important regulatory role by functioning as an autoinhibitor which occupies the ligand binding groove and blocks the binding of inappropriate ligands. Whether the same holds true or not for the yeast isoforms is unclear. Therefore, we investigated the conformational behavior of the C-terminal segment of BMH proteins using various biophysical techniques. Dynamic light scattering, sedimentation velocity, time-resolved fluorescence anisotropy decay, and size exclusion chromatography measurements showed that the molecules of BMH proteins are significantly larger compared to the human 14-3-3zeta isoform. On the other hand, the sedimentation analysis confirmed that BMH proteins form dimers. Time-resolved tryptophan fluorescence experiments revealed no dramatic structural changes of the C-terminal segment upon the ligand binding. Taken together, the C-terminal segment of BMH proteins adopts a widely opened and extended conformation that makes difficult its folding into the ligand binding groove, thus increasing the apparent molecular size. It seems, therefore, that the C-terminal segment of BMH proteins does not function as an autoinhibitor.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025092
003      
CZ-PrNML
005      
20130226195102.0
007      
ta
008      
120816s2010 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1021/bi100273k $2 doi
035    __
$a (PubMed)20384366
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Veisová, Dana. $7 _AN071488 $u Institute of Physiology, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic.
245    14
$a The C-terminal segment of yeast BMH proteins exhibits different structure compared to other 14-3-3 protein isoforms / $c D. Veisova, L. Rezabkova, M. Stepanek, P. Novotna, P. Herman, J. Vecer, T. Obsil, V. Obsilova
520    9_
$a Yeast 14-3-3 protein isoforms BMH1 and BMH2 possess a distinctly variant C-terminal tail which differentiates them from the isoforms of higher eukaryotes. Their C-termini are longer and contain a polyglutamine stretch of unknown function. It is now well established that the C-terminal segment of 14-3-3 proteins plays an important regulatory role by functioning as an autoinhibitor which occupies the ligand binding groove and blocks the binding of inappropriate ligands. Whether the same holds true or not for the yeast isoforms is unclear. Therefore, we investigated the conformational behavior of the C-terminal segment of BMH proteins using various biophysical techniques. Dynamic light scattering, sedimentation velocity, time-resolved fluorescence anisotropy decay, and size exclusion chromatography measurements showed that the molecules of BMH proteins are significantly larger compared to the human 14-3-3zeta isoform. On the other hand, the sedimentation analysis confirmed that BMH proteins form dimers. Time-resolved tryptophan fluorescence experiments revealed no dramatic structural changes of the C-terminal segment upon the ligand binding. Taken together, the C-terminal segment of BMH proteins adopts a widely opened and extended conformation that makes difficult its folding into the ligand binding groove, thus increasing the apparent molecular size. It seems, therefore, that the C-terminal segment of BMH proteins does not function as an autoinhibitor.
650    _2
$a proteiny 14-3-3 $x chemie $x genetika $x metabolismus $7 D048948
650    _2
$a aminokyselinové motivy $7 D020816
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a dimerizace $7 D019281
650    _2
$a lidé $7 D006801
650    _2
$a molekulární sekvence - údaje $7 D008969
650    _2
$a konformace proteinů $7 D011487
650    _2
$a terciární struktura proteinů $7 D017434
650    _2
$a Saccharomyces cerevisiae $x chemie $x genetika $x metabolismus $7 D012441
650    _2
$a Saccharomyces cerevisiae - proteiny $x chemie $x genetika $x metabolismus $7 D029701
650    _2
$a sekvenční seřazení $7 D016415
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1#
$a Řežábková, Lenka. $7 xx0201118
700    1#
$a Štěpánek, Miroslav. $7 uk2007351446
700    1#
$a Novotná, Pavlína. $7 _AN071490
700    1_
$a Heřman, Petr, $d 1953- $7 mzk2005317907
700    1_
$a Večeř, Jaroslav $7 xx0119411
700    1_
$a Obšil, Tomáš, $d 1972- $7 uk2007304264
700    1_
$a Obšilová, Veronika, $d 1972- $7 xx0107730
773    0_
$w MED00009310 $t Biochemistry $x 1520-4995 $g Roč. 49, č. 18 (2010), s. 3853-3861
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20384366 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120816 $b ABA008
991    __
$a 20130226195317 $b ABA008
999    __
$a ok $b bmc $g 947134 $s 782438
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 49 $c 18 $d 3853-3861 $i 1520-4995 $m Biochemistry (Easton) $n Biochemistry $x MED00009310
LZP    __
$a Pubmed-20120816/10/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...